情報源 > 更に詳しい情報[015]
参考文献

(1) Bartalena. L., Marcocci. C., Bogazzi. F., Panicucci. M.. Lepri. A. & Pinchera, A. (1989) Use of corticos'teroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism . New England Journal of Medicine. 321, 1349-1352.
(2) Bartalena. L., Marcocci, C., Bogazzi. F.. Bruno-Bossi. G., Tanda, M.L., Vanni, G., Dell'Unto, E., Martino. E. & Pinchera, A. (1995) Further stuLlles on thc course of Graves' ophthalmoptrthy f'ollowing radioactive iodine administration. Thyroid, 5 (Suppl. l) S-70.
(3) Bartley, G.B. (1994) The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota. Transactions of the American Ophthalrnological Society, 92, 477-588.
(4) Bartley, G.B. (1995) Evolution of classification systems for Graves' ophthalmopathy. Ophthal,nic, Plastic and Rec'onstuc'tive Sttrgery, 11, 229-237.
(5) Burch, H.B. & Wartofsky, L. (1993) Graves' ophthalmopathy: current concepts regarding pathogenesis and management. Endocrine Reviews, 14, 747-793.
(6) DeGroot. L.J., Gorman, C.A., Pinchera, A., Bartalena, L., Marcocci, C., Wiersinga, W.M., Prummel, M.F. & Wartofsky, L. (1995) Radiation and Graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism, 80, 339-349.
(7) European Thyrold Association, Japanese Thyroid Association, AsianOceania Thyroid Association, Latin-American Thyroid Association, American Thyroid Association (1992) Classification of Graves' disease. Thyroid, 2, 235-236.
(8) Frueh, B.R. (1992) Why the NO SPECS classification of Graves' eye disease should be abandoned, with suggestions for the characterization of this disease. Thyroid, 2, 85-88.
(9) Glinoer, D., Hesch, D., Lagasse, R. & Laurberg, P. (1987) The management of hyperthyroidism due to Graves' disease in Europe in 1986. Results of an intemational survey. Acta Endocrinologica, 115 (Suppl. 285), 1-23.
(10) Gorman. C.A. (1991) Clever is not enough: NO SPECS Is form in search of function. Thyroid, 1, 353-355.
(11) Gorman, C.A. (1995) Radioiodine therapy does not aggravate Graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism, 80, 340-342.
(12) Mourits, M.P., Koomneef. L., Wiersinga, W.M.. Prummel, M.F.. Berghout. A. & van der Gaag, R. (1989) Clinical criteria for the a novel assessment of disease activity in Graves' ophthalmopathy: approach. British Journal of Ophthalmology, 73, 639-644.
(13) Mourits, M.P., Kvornneef, L.. Wiersinga, W.M., Prummei. M.F.. Berghout, A. & van der Gaag, R. (1990) Orbital decompression for Graves' ophthalmopathy by inferomedial, by inferomedial plus lateral, and by coronal approach. Ophthalmology, 97, 636-641.
(14) Nagayama, Y., Izumi, M. & Nagataki, S. (1989) The management of hyperthyroidism due to Graves' disease in Japan in 1988. Endocrinologica Japonica, 36, 299-314.
(15) Polak, B.C.P. & Wijngaarde, R. (1995) Radiation retinopathy m patients with both diabetes mellitus and ophthalmic Graves' disease. Orbit, 14, 71-74.
(16) Prummel, M.F. & Wiersinga, W.M. (1993) Smoking and the risk of Graves' disease. Journal of the American Medical Association, 269, 479-482.
(17) Shine, B., Fells, P., Edwards, O.M. & Weetman, A.P. (1990) Association between Graves' ophthalmopathy and smoking. Lancet, 335, 1261-1263.
(18) Solomon. B., Glinoer, D., Lagasse, R. & Wartofsky, L. (1990) Current trends in the management of Graves' disease. Journal of Clinical Endocrinology and Metabolism, 70, 1518-1524.
(19) Tallstedt. L., Lundell, G., T「ning, O.. Wallin, G., Ljunggren, J.G., Blomgren, H., Taube, A. & the Thyroid Study Group. (1992) Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. New England Journal of Medicine, 326, 1733-1738.
(20) Werner, S.C. (1977) Modification of the classification of the eye changes of Graves' disease: recommendations of the Ad Hoc Committee of the American Thyroid Association. Journal of Clinical Endocrinology and Metabolism. 44, 203-204.
(21) Wiersinga, W.M., Prummel, M.F., Mourits. M.P.H., Koornneef, L. & Buller, H.R. (1991) Classification of the eye changes of Graves' disease. Thyroid, l, 357-360.
(22) Winsa. B., Rastad, J., Akerstrbm. G., Johansson, H., Westermark, K. & Karlsson, F.A. (1995) Retrospective evaluation of subtotal and total thyroidectomy in Graves' disease with and without endocrine ophthalmopathy. European Joumal of Endocrinology, 132, 406-412.

もどる